Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

Foreign Product Alert: Lami Capsules

Starting date:
February 7, 2014
Posting date:
February 7, 2014
Type of communication:
Foreign Product Alert (FPA)
Subcategory:
Natural health products
Source of recall:
Health Canada
Source of alert:

Hong Kong Department of Health

Issue:
Undeclared Substance
Audience:
General Public
Identification number:
RA-37709

Introduction

This product is not authorized for sale in Canada and has not been found in the Canadian marketplace, but it is possible it may have been brought into the country by travellers or purchased over the Internet.

Affected product

  • Lami Capsules

Lami Capsules

Product description

This product is promoted for weight loss.

Hazard identified

The Hong Kong Department of Health warned consumers not to use this product after it was found to contain sibutramine, a drug ingredient that was not declared on the label.

  • Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side effects such as heart attack and stroke.

Place of origin

According to the product packaging, the product originates from Indonesia.

Side effects

In addition to heart attack and stroke, side effects associated with sibutramine include increased blood pressure and heart rate, dry mouth, difficulty sleeping and constipation.

What you should do

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed above in the Canadian marketplace.

Canadians who have this product are advised not to use it, and should consult with a healthcare professional if they have concerns about their health related to the use of this product.

Background

Drugs and natural health products that are authorized for sale in Canada will have an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

As of December 31, 2013, no adverse reactions suspected to be associated with the use of this product have been reported to Health Canada.

Report a health or safety concern

To report a side effect to a health product to Health Canada:

  • Call toll-free at 1-866-234-2345

Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

Archived – Lami

2009-02-25 | Health products

Advisory

Images

Select thumbnail to enlarge - opens in a new window